I am a physician-scientist focusing on melanoma. I continue to see patients and spend 80% of my time doing research. I currently serve as the Director of the Interdisciplinary Melanoma Cooperative Group (IMCG), an active translational research program that includes 24 investigators representing 10 departments at New York University. I am also the Associate Director of the NYU Cancer Institute for Interdisciplinary Program Development. I have published extensively in the area of molecular characterization of cancer, focusing on identifying potential new molecular targets for treatment of melanoma.
Our organization core mission is aligned with WIN’s mission.